In these studies, PSMA PET/CT was performed for staging and restaging of RCC, evaluation of primary RCC lesions, or other purposes (e.g., prostate cancer restaging) with incidental detection of RCC metastases. Here, FOLH1 is linked to prostate carcinoma.